CA2881067C - Method and device for determining sample application - Google Patents

Method and device for determining sample application Download PDF

Info

Publication number
CA2881067C
CA2881067C CA2881067A CA2881067A CA2881067C CA 2881067 C CA2881067 C CA 2881067C CA 2881067 A CA2881067 A CA 2881067A CA 2881067 A CA2881067 A CA 2881067A CA 2881067 C CA2881067 C CA 2881067C
Authority
CA
Canada
Prior art keywords
reflectance
sample
sample application
application condition
test element
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CA2881067A
Other languages
English (en)
French (fr)
Other versions
CA2881067A1 (en
Inventor
Gertrud Albrecht
Otto Gaa
Robert Lorenz
Frank RUECKERT
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of CA2881067A1 publication Critical patent/CA2881067A1/en
Application granted granted Critical
Publication of CA2881067C publication Critical patent/CA2881067C/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/66—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood sugars, e.g. galactose
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/84—Systems specially adapted for particular applications
    • G01N21/8483—Investigating reagent band
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/17—Systems in which incident light is modified in accordance with the properties of the material investigated
    • G01N21/55—Specular reflectivity
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/14—Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
    • Y10T436/142222—Hetero-O [e.g., ascorbic acid, etc.]
    • Y10T436/143333—Saccharide [e.g., DNA, etc.]
    • Y10T436/144444—Glucose

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Diabetes (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Investigating Or Analysing Materials By Optical Means (AREA)
CA2881067A 2012-09-05 2013-09-05 Method and device for determining sample application Active CA2881067C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP12183225 2012-09-05
EP12183225.7 2012-09-05
PCT/EP2013/068401 WO2014037462A1 (en) 2012-09-05 2013-09-05 Method and device for determining sample application

Publications (2)

Publication Number Publication Date
CA2881067A1 CA2881067A1 (en) 2014-03-13
CA2881067C true CA2881067C (en) 2018-06-26

Family

ID=46799151

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2881067A Active CA2881067C (en) 2012-09-05 2013-09-05 Method and device for determining sample application

Country Status (7)

Country Link
US (1) US9869679B2 (enExample)
EP (1) EP2893328B1 (enExample)
JP (1) JP6116692B2 (enExample)
KR (1) KR101701072B1 (enExample)
CN (1) CN104603602B (enExample)
CA (1) CA2881067C (enExample)
WO (1) WO2014037462A1 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10983064B2 (en) * 2015-11-23 2021-04-20 Roche Diabetes Care, Inc. Method and apparatus for determining the concentration of an analyte in a body fluid
EP3315069A1 (en) * 2016-10-25 2018-05-02 Roche Diabetes Care GmbH Method for determination of an analyte concentration in a body fluid and analyte concentration measurement device
CN110186869B (zh) 2018-02-23 2023-08-15 三星电子株式会社 用于估计血液化合物浓度的装置和方法
KR102031340B1 (ko) * 2018-03-14 2019-10-11 주식회사 필로시스 혈당 측정 장치, 방법, 및 시스템
PT3650843T (pt) 2018-11-07 2022-03-11 Hoffmann La Roche Métodos e dispositivos para realizar uma medição analítica

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS55106360A (en) * 1979-02-09 1980-08-15 Hitachi Ltd Automatic chemical analyzer
JPS61218948A (ja) * 1985-03-25 1986-09-29 Toshiba Corp 分析装置
JPH0810193B2 (ja) * 1989-08-21 1996-01-31 富士写真フイルム株式会社 生化学分析方法における点着異常判定方法
WO1991019187A1 (en) * 1990-06-04 1991-12-12 Pb Diagnostic Systems, Inc. Analytical assay
AU702209B2 (en) * 1996-07-16 1999-02-18 Roche Diagnostics Gmbh Analytical system with means for detecting too small sample volumes
CN1131425C (zh) * 1997-10-31 2003-12-17 技术化学品及产品股份有限公司 反射计
DE19932846A1 (de) 1999-07-14 2001-01-18 Lre Technology Partner Gmbh Verfahren zur Erkennung der Fehlpositionierung eines optisch auswertbaren Teststreifens und Teststreifen hierfür
PL189890B1 (pl) 1999-09-14 2005-10-31 Kazmierski Jan Zaklad Prod Usl Preparat do ochrony roślin przed chorobami
WO2001025760A1 (en) * 1999-10-07 2001-04-12 Umm Electronics, Inc. Timing independent method for determining a proper time for measurement of a reaction between a sample fluid and a reagent
EP1305607A1 (en) * 2000-07-31 2003-05-02 Lifescan, Inc. Method and apparatus for detecting the presence of a fluid on a test strip
JP2002340888A (ja) * 2001-05-10 2002-11-27 Advance Co Ltd 体液検査装置
DE10163775A1 (de) * 2001-12-22 2003-07-03 Roche Diagnostics Gmbh Analysensystem zur Bestimmung einer Analytkonzentration unter Berücksichtigung von proben- und analytunabhängigen Lichtintensitätsänderungen
PL1921441T3 (pl) * 2006-11-07 2014-02-28 Hoffmann La Roche Sposób analizowania próbki na elemencie testowym i system analityczny
AU2009200129B2 (en) * 2008-01-18 2015-06-25 Lifescan Scotland Limited Analyte testing method and system
JP2010019610A (ja) * 2008-07-09 2010-01-28 Panasonic Corp 免疫クロマトグラフィー測定装置および免疫クロマトグラフィー測定方法
EP2221608B1 (de) * 2009-02-18 2015-08-12 F. Hoffmann-La Roche AG Testverfahren zur Untersuchung einer Körperflüssigkeit
JP5270501B2 (ja) * 2009-09-17 2013-08-21 テルモ株式会社 血糖計及び血糖値測定方法

Also Published As

Publication number Publication date
US9869679B2 (en) 2018-01-16
EP2893328A1 (en) 2015-07-15
CN104603602A (zh) 2015-05-06
KR101701072B1 (ko) 2017-01-31
CA2881067A1 (en) 2014-03-13
KR20150038603A (ko) 2015-04-08
EP2893328B1 (en) 2017-02-22
HK1210263A1 (en) 2016-04-15
WO2014037462A1 (en) 2014-03-13
CN104603602B (zh) 2017-03-08
JP6116692B2 (ja) 2017-04-19
JP2015527591A (ja) 2015-09-17
US20150177257A1 (en) 2015-06-25

Similar Documents

Publication Publication Date Title
JP6356691B2 (ja) ヘマトクリットを補正する方法およびそのために適合させた血糖測定器
CN102326069B (zh) 用于化验体液的测试方法和测试设备
US20200158655A1 (en) Methods of Determining an Analyte Concentration in a Body Fluid Sample Having Disturbance Variables, as Well as Computer Programs and Devices Therefor
EP2893328B1 (en) Method and device for determining sample application
EP2950083B1 (en) Calibration method, device, and program, and bodily-fluid component measurement device calibrated using said method
US8570519B2 (en) Method and device for analyzing a body fluid
HK1210263B (en) Method and device for determining sample application
EP3380839B1 (en) Method and apparatus for determining the concentration of an analyte in a body fluid
US11262350B2 (en) Detection of ascorbic acid in a urine sample
HK1262407B (en) Method and apparatus for determining the concentration of an analyte in a body fluid
HK1262407A1 (en) Method and apparatus for determining the concentration of an analyte in a body fluid
HK1213637B (en) Method for analyzing a sample of a body fluid

Legal Events

Date Code Title Description
EEER Examination request

Effective date: 20150205

MPN Maintenance fee for patent paid

Free format text: FEE DESCRIPTION TEXT: MF (PATENT, 11TH ANNIV.) - STANDARD

Year of fee payment: 11

U00 Fee paid

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED

Effective date: 20240830

U11 Full renewal or maintenance fee paid

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT DETERMINED COMPLIANT

Effective date: 20241218

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL

Effective date: 20241218

MPN Maintenance fee for patent paid

Free format text: FEE DESCRIPTION TEXT: MF (PATENT, 12TH ANNIV.) - STANDARD

Year of fee payment: 12

U00 Fee paid

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED

Effective date: 20250820

U11 Full renewal or maintenance fee paid

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL

Effective date: 20250820